These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 460339)
21. Transfusion-associated hepatitis and AIDS. What is the risk? Bove JR N Engl J Med; 1987 Jul; 317(4):242-5. PubMed ID: 3110619 [TBL] [Abstract][Full Text] [Related]
22. [Post-transfusion hepatitis: the point of view of the infectious disease specialist]. Giusti G; Galanti B Ric Clin Lab; 1984; 14 Suppl 1():3-16. PubMed ID: 6429829 [No Abstract] [Full Text] [Related]
23. Frozen blood. Chaplin H N Engl J Med; 1978 Mar; 298(12):679-81. PubMed ID: 628390 [No Abstract] [Full Text] [Related]
27. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion]. Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054 [No Abstract] [Full Text] [Related]
28. The large scale use of frozen blood by the hospital blood bank. Bryant LR Am J Med Technol; 1977 Aug; 43(8):785-9. PubMed ID: 888858 [TBL] [Abstract][Full Text] [Related]
29. The declining risk of post-transfusion hepatitis C virus infection. Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736 [TBL] [Abstract][Full Text] [Related]
30. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Seed CR; Kiely P; Keller AJ Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258 [TBL] [Abstract][Full Text] [Related]
31. Efficacy control of HB blood donor screening. Fiedler H Haematologia (Budap); 1983; 16(1-4):99-104. PubMed ID: 6679491 [TBL] [Abstract][Full Text] [Related]
32. Frozen-thawed red cells--standard article for hospital use? Schneider W; McCarty LJ Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(3):318-24. PubMed ID: 52578 [TBL] [Abstract][Full Text] [Related]
33. Post-transfusion hepatitis. Sudden drop of its incidence associated with hyperbilirubinemic donors disqualification. Pintera J; Krácmar C; Pinterová A Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):415-25. PubMed ID: 2428716 [TBL] [Abstract][Full Text] [Related]
35. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. Alter HJ; Purcell RH; Holland PV; Alling DW; Koziol DE JAMA; 1981 Aug; 246(6):630-4. PubMed ID: 6788964 [TBL] [Abstract][Full Text] [Related]
36. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends. Singh B; Verma M; Verma K Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208 [TBL] [Abstract][Full Text] [Related]
37. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors. N Engl J Med; 1981 Aug; 305(7):403-4. PubMed ID: 6789203 [No Abstract] [Full Text] [Related]
38. [Contribution to the task of reducing the incidence of post transfusion non-A, non-B hepatitis]. Hernández Sánchez MC; Vila Enriquez P; Alvarez Hernández M Sangre (Barc); 1989 Jun; 34(3):248-9. PubMed ID: 2503897 [No Abstract] [Full Text] [Related]
39. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients]. Sugg U Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972 [No Abstract] [Full Text] [Related]